Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay

Jpn J Pharmacol. 1987 Mar;43(3):277-82. doi: 10.1254/jjp.43.277.

Abstract

Quantitative evaluation of antimuscarinic effects of antihistamines (H1- and H2-receptor antagonists) was carried out using a receptor-binding assay. The -inhibition constants (Ki values) of twenty seven H1-receptor antagonists, one related antidepressant and three H2-receptor antagonists at H1-receptors and muscarinic receptors in the bovine cerebral cortex were determined. All the H2-receptor antagonists examined showed very low affinity for the muscarinic receptors. On the other hand, some H1-receptor antagonists (mequitazine, cyproheptazine, clemastine, diphenylpyraline, promethazine, homochlorcyclizine and alimemazine) had high affinity for the muscarinic receptors (Ki = 5.0-38 nM). Another group of H1-receptor antagonists (mepyramine, terfenadine, metapyrilen, azelastine, hydroxyzine and meclizine) had low affinity for the muscarinic receptors (Ki = 3,600-30,000 nM). Thus, a broad range of antimuscarinic potencies among the antihistamines was demonstrated. These results should provide helpful information with regard to the clinical and experimental use of antihistamines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / metabolism
  • Cattle
  • Cerebral Cortex / drug effects
  • Histamine Antagonists / pharmacology*
  • Histamine H1 Antagonists / pharmacology
  • Histamine H2 Antagonists / pharmacology
  • In Vitro Techniques
  • Kinetics
  • Membranes / drug effects
  • Membranes / metabolism
  • Parasympatholytics*
  • Pyrilamine / metabolism
  • Quinuclidinyl Benzilate
  • Radioligand Assay
  • Receptors, Muscarinic / drug effects*

Substances

  • Antidepressive Agents
  • Histamine Antagonists
  • Histamine H1 Antagonists
  • Histamine H2 Antagonists
  • Parasympatholytics
  • Receptors, Muscarinic
  • Quinuclidinyl Benzilate
  • Pyrilamine